Skip to main content
Jeffrey Gelfand, MD, Infectious Disease, Boston, MA

Jeffrey A Gelfand MD

Healthcare Associated Infections, Transplant/Immunocompromised States, Microbiology


Clinical Professor of Medicine, Harvard Medical School

Join to View Full Profile
  • 55 Fruit StS50801 Infectious Disease AssociatesBoston, MA 02114

  • Phone+1 617-726-1796

  • Fax+1 617-726-2894

Dr. Gelfand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityChief Residency, Internal Medicine, 1976 - 1977
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1974 - 1976
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1971 - 1973
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1971
  • University of Pennsylvania
    University of PennsylvaniaA.B., Honors, 1967

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1977 - 2025
  • MD State Medical License
    MD State Medical License 1973 - 1982
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Fellow AAAS, 2007
  • Edward M. Kennedy Award CIMIT, 2005
  • New England Business and Technology Award 2004
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Brief Exposure of Skin to near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response  
    Jeffrey Gelfand, Mark C Poznansky, The Journal of Immunology
  • A Novel Laser Vaccine Adjuvant Increases the Motility of Antigen Presenting Cells  
    Chen X, Kim P, Farinelli W, Doukas A, Gelfand JA, Anderson RR and Wu MX, PLoS One, 10/1/2010
  • Increased Dense Erythrocytes in Flame-burned Patients  
    Saavedra A, Norton K, Burke J, Warth J, Gelfand J, Clin Hemorheol Microcirc, 1/1/2013
  • Join now to see all

Press Mentions

  • Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with the Vaccine &Amp; Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
    Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with the Vaccine &Amp; Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer VaccineJune 9th, 2020
  • Hoth Update on HaloVax Partnership Vaccine to Fight COVID-19 with Sponsored Research Agreement with the Vaccine and Immunotherapy Center (VIC) of the Massachusetts General Hospital (MGH)
    Hoth Update on HaloVax Partnership Vaccine to Fight COVID-19 with Sponsored Research Agreement with the Vaccine and Immunotherapy Center (VIC) of the Massachusetts General Hospital (MGH)April 2nd, 2020
  • HaloVax Announces Agreement with Hoth Therapeutics
    HaloVax Announces Agreement with Hoth TherapeuticsMarch 29th, 2020
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: